What is the reported range of variability in response rate for diseases such as Alzheimer's, depression, RA, hypertension, and osteoporosis?

• A. 30-60%
• B. 5-15%
• C. 60-90%
• D. 10-20%

Answer: (A)

Response to treatment in these chronic diseases shows substantial variability among individuals due to differences in how bodies handle drugs, how diseases manifest in each person, and how well therapy is followed. When you look across Alzheimer's, depression, rheumatoid arthritis, hypertension, and osteoporosis, the typical proportion of patients achieving a meaningful clinical response with standard therapies tends to fall in a broad middle range—about 30% to 60%. This reflects that a substantial number benefit, but a sizable portion do not reach predefined response criteria, while others respond quite well. Factors contributing include genetic differences in drug metabolism and receptor sensitivity, age and organ function, comorbidities and drug interactions, adherence, and how response is defined and measured. The other ranges are less representative of the real-world spread across these diverse conditions, making 30-60% the best fit.